196 related articles for article (PubMed ID: 23803143)
1. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
[TBL] [Abstract][Full Text] [Related]
2. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
3. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
4. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
[TBL] [Abstract][Full Text] [Related]
5. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
[TBL] [Abstract][Full Text] [Related]
6. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Di Sciascio G
Am J Cardiol; 2016 Oct; 118(7):980-4. PubMed ID: 27515894
[TBL] [Abstract][Full Text] [Related]
7. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
Cuisset T; Hamilos M; Sarma J; Sarno G; Wyffels E; Vanderheyden M; Barbato E; Bartunek J; De Bruyne B; Wijns W
Am J Cardiol; 2008 Jun; 101(12):1700-3. PubMed ID: 18549843
[TBL] [Abstract][Full Text] [Related]
8. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome.
Ozcan OU; Ustun EE; Gulec S; Gerede DM; Goksuluk H; Vurgun VK; Kaya CT; Erol C
Cardiol J; 2015; 22(3):323-9. PubMed ID: 25563711
[TBL] [Abstract][Full Text] [Related]
10. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
[TBL] [Abstract][Full Text] [Related]
11. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
[TBL] [Abstract][Full Text] [Related]
12. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris.
Okada T; Yoshikawa D; Ishii H; Matsumoto M; Hayakawa S; Matsudaira K; Tanaka M; Kumagai S; Hayashi M; Ando H; Amano T; Murohara T
J Cardiol; 2012 Oct; 60(4):264-9. PubMed ID: 22738692
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
14. The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention.
Layland JJ; Whitbourn RJ; Burns AT; Somaratne J; Leitl G; Macisaac AI; Wilson A
Heart; 2012 Oct; 98(20):1492-7. PubMed ID: 22895644
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
Li JS; Zhao XJ; Ma BX; Wang Z
J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
[TBL] [Abstract][Full Text] [Related]
16. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
Verdoia M; Camaro C; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
[TBL] [Abstract][Full Text] [Related]
17. Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation.
Osugi N; Suzuki S; Ishii H; Yasuda Y; Shibata Y; Tatami Y; Ota T; Kawamura Y; Okumura S; Tanaka A; Inoue Y; Matsuo S; Murohara T
Am J Cardiol; 2014 Jul; 114(1):42-6. PubMed ID: 24802297
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
[TBL] [Abstract][Full Text] [Related]
19. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
20. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
